Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
46-60 of 4547 results
Moffitt researchers discover new targets for approved cancer drug
A team of researchers at Moffitt Cancer Center used cellular drug screening, functional proteomics and computer-based modeling to determine whether drugs with well-known targets may be repurposed for use against other biological targets.
Drug Research > Drug Discovery & Development > News
PanOptica secures $11m to advance clinical development novel topical anti-VEGF eye drop
PanOptica a private biopharmaceutical company focused on developing innovative ophthalmology therapies, announced that it has secured $11m in a series B financing.
Drug Research > Drug Discovery & Development > News
Visterra closes $46.7m series C financing to advance pipeline of precision antibody-based biological medicines
Visterra has completed a series C financing round raising a total of $46.7m, including a new extension totaling $23.6m.
Drug Research > Drug Discovery & Development > News
Ligand to acquire Crystal Bioscience
Ligand Pharmaceuticals has announced the signing of a merger agreement whereby Ligand will acquire Crystal, a leader in avian genetics and the generation of fully-human therapeutic antibodies.
Drug Research > Drug Discovery & Development > News
Recursion Pharmaceuticals raises $60m to industrialize drug discovery using artificial intelligence
Recursion Pharmaceuticals, a biotechnology company that combines innovative biological science with artificial intelligence to discover new therapeutics at scale, is announcing its $60m series B financing led by Data Collective (DCVC).
Drug Research > Drug Discovery & Development > News
Amgen, CytomX partner to develop immuno-oncology drugs
By PBR Staff Writer
Amgen has partnered with CytomX Therapeutics to develop and commercialize new immuno-oncology drugs.
Drug Research > Drug Discovery & Development > News
Immatics secures funding to develop T-cell receptor based immunotherapies
By PBR Staff Writer
Immatics has secured $58m of funding for the development of T-cell receptor based immunotherapies.
Drug Research > Drug Discovery & Development > News
X-Chem further expands collaboration with Bayer to discover novel medicines
X-Chem and Bayer have further expanded their drug discovery collaboration across multiple therapeutic areas and target classes.
Drug Research > Drug Discovery & Development > News
Gilead Sciences completes acquisition of Kite Pharma
Gilead Sciences has announced the completion of the previously announced transaction for Dodgers Merger Sub a wholly-owned subsidiary of Gilead (purchaser), to acquire Kite Pharma, for $180 per share, net to the seller in cash, without interest, or approximately $11.9bn in the aggregate.
Drug Research > Drug Discovery & Development > News
US HHS accelerates development of first Ebola vaccines and drugs
The US Department of Health & Human Services (HHS) has accelerated the development of first Ebola vaccines and drugs.
Drug Research > Drug Discovery & Development > News
Novartis, UC Berkeley collaborate to tackle undruggable disease targets
Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered undruggable.
Drug Research > Drug Discovery & Development > News
Evotec buys stake in Exscientia to advance AI-based drug discovery
By PBR Staff Writer
Germany-based Evotec has acquired a minority stake worth €15m in Exscientia to advance the British company’s artificial intelligence (AI)-driven drug discovery.
Drug Research > Drug Discovery & Development > News
Jacobs secures contract from Ferring Pharmaceuticals for research and development headquarters in Copenhagen
Jacobs Engineering Group received an engineering, procurement, construction management and validation (EPCmV) services contract for the new Ferring Pharmaceuticals research and development (R&D) headquarters, which will be located in Copenhagen, Denmark.
Drug Research > Drug Discovery & Development > News
Autolus secures $80m series C funding
Autolus, a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies, announced that it closed on a $80m (£59m) series C financing.
Drug Research > Drug Discovery & Development > News
46-60 of 4547 results